Efforts to Increase Representation in Prostate Cancer Clinical Trials
This study at Lyndon B. Johnson Hospital aims to increase the number of men from diverse racial and ethnic backgrounds who join prostate cancer clinical trials. Researchers will use a short video in the clinic, along with educational sessions for healthcare providers and support from a nurse navigator, to help more patients participate. You might be able to join if you are an adult man with prostate cancer receiving care at LBJ Hospital, are eligible for another open prostate cancer clinical trial there, and can give informed consent. The main goal is to see if these efforts improve enrollment and how well participants stay in trials for one year. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 60 participants. It will test the impact of a culturally tailored video and other interventions on clinical trial participation.
- What's involved
- Participants will watch a short video in the clinic and complete two questionnaires before and after viewing it. The study will track safety and adverse events for about one year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for safety and adverse events through study completion, which is an average of one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Debanjan Pain, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Safety and Adverse Events (AEs)Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0